Burlington, Massachusetts–(Newsfile Corp. – September 27, 2024) – Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced that it has received the Endpoints 11 Award from Endpoints News, an honor given to the most promising biotech startups of 2024. Lifordi is leading the way […]